H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 77 Citations 24,473 336 World Ranking 11073 National Ranking 507

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

His primary areas of study are Cancer research, Pathology, IDH1, Astrocytoma and IDH2. His study in Oligodendroglioma and Glioma are all subfields of Cancer research. He combines subjects such as Exome sequencing, V600E and Solitary fibrous tumor with his study of Pathology.

Felix Sahm works mostly in the field of IDH1, limiting it down to topics relating to ATRX and, in certain cases, Brain tumor, Pilocytic astrocytoma, Neuropathology and DNA sequencing. As a member of one scientific family, Felix Sahm mostly works in the field of Astrocytoma, focusing on Immunohistochemistry and, on occasion, Monoclonal. His research in IDH2 intersects with topics in Medulloblastoma and 1p/19q Codeletion.

His most cited work include:

  • An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor (1047 citations)
  • DNA methylation-based classification of central nervous system tumours (733 citations)
  • DNA methylation-based classification of central nervous system tumours (733 citations)

What are the main themes of his work throughout his whole career to date?

Felix Sahm mainly investigates Cancer research, Pathology, DNA methylation, Glioma and Internal medicine. In his study, which falls under the umbrella issue of Cancer research, Oligodendroglioma is strongly linked to IDH1. In his research on the topic of Pathology, ATRX is strongly related with Astrocytoma.

His research investigates the connection between DNA methylation and topics such as Epigenetics that intersect with issues in Medulloblastoma. Glioma and Isocitrate dehydrogenase are two areas of study in which he engages in interdisciplinary work. In his study, Temozolomide, Radiation therapy, Clinical trial and Glioblastoma is inextricably linked to Oncology, which falls within the broad field of Internal medicine.

He most often published in these fields:

  • Cancer research (61.65%)
  • Pathology (44.70%)
  • DNA methylation (37.08%)

What were the highlights of his more recent work (between 2020-2021)?

  • DNA methylation (37.08%)
  • Cancer research (61.65%)
  • Pathology (44.70%)

In recent papers he was focusing on the following fields of study:

His main research concerns DNA methylation, Cancer research, Pathology, Meningioma and Methylation. His DNA methylation research incorporates elements of Oncology, Internal medicine, Uterus, Mutation and CDKN2A. His is doing research in Glioma and Astrocytoma, both of which are found in Cancer research.

The Pathology study combines topics in areas such as Choroid plexus papilloma, Fusion transcript and Oligodendroglioma. His Meningioma study combines topics from a wide range of disciplines, such as Immunohistochemistry, Clinicopathological features, Who classification, Brain tumor and Hazard ratio. His studies deal with areas such as Somatic cell, Fusion gene, Subclass, Pilocytic astrocytoma and Sarcoma as well as Methylation.

Between 2020 and 2021, his most popular works were:

  • Sarcoma classification by DNA methylation profiling (12 citations)
  • Sarcoma classification by DNA methylation profiling (12 citations)
  • A vaccine targeting mutant IDH1 in newly diagnosed glioma. (6 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Glioma, Cancer research, Cell biology, DNA methylation and Astrocytoma are his primary areas of study. His Glioma research includes themes of Niche, Missense mutation, H3 K27M Mutation, Epidermal growth factor receptor and IDH1. His Cancer research research is multidisciplinary, incorporating elements of DNA damage, Mutation, ATRX, MSH2 and EGFR Gene Amplification.

The various areas that Felix Sahm examines in his Cell biology study include Cell culture, Downregulation and upregulation, Multicellular organism, Receptor and Cytotoxic T cell. His DNA methylation research is multidisciplinary, incorporating perspectives in Methylation and Sarcoma, Pathology. His Astrocytoma research integrates issues from MLH1, MSH6, Germline mutation and DNA mismatch repair.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Christiane A. Opitz;Ulrike M. Litzenburger;Ulrike M. Litzenburger;Felix Sahm;Martina Ott.
Nature (2011)

1305 Citations

DNA methylation-based classification of central nervous system tumours

David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt.
Nature (2018)

860 Citations

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Julien Haroche;Frédéric Charlotte;Laurent Arnaud;Andreas von Deimling.
Blood (2012)

530 Citations

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

David Capper;David Capper;Matthias Preusser;Matthias Preusser;Antje Habel;Felix Sahm;Felix Sahm.
Acta Neuropathologica (2011)

529 Citations

A vaccine targeting mutant IDH1 induces antitumour immunity

Theresa Schumacher;Theresa Schumacher;Lukas Bunse;Lukas Bunse;Stefan Pusch;Stefan Pusch;Felix Sahm;Felix Sahm.
Nature (2014)

516 Citations

Brain tumour cells interconnect to a functional and resistant network

Matthias Osswald;Matthias Osswald;Erik Jung;Erik Jung;Felix Sahm;Felix Sahm;Gergely Solecki;Gergely Solecki.
Nature (2015)

486 Citations

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt.
Cell (2016)

479 Citations

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.

David E. Reuss;Felix Sahm;Felix Sahm;Daniel Schrimpf;Daniel Schrimpf;Benedikt Wiestler;Benedikt Wiestler.
Acta Neuropathologica (2015)

424 Citations

Lomustine and Bevacizumab in Progressive Glioblastoma

Wolfgang Wick;Thierry Gorlia;Martin Bendszus;Martin Taphoorn.
The New England Journal of Medicine (2017)

395 Citations

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Felix Sahm;Felix Sahm;Daniel Schrimpf;Damian Stichel;David T.W. Jones.
Lancet Oncology (2017)

330 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Felix Sahm

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 172

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 155

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 138

David Capper

David Capper

Humboldt-Universität zu Berlin

Publications: 131

Michael Weller

Michael Weller

University of Zurich

Publications: 106

Arie Perry

Arie Perry

University of California, San Francisco

Publications: 70

David T. W. Jones

David T. W. Jones

German Cancer Research Center

Publications: 67

Pieter Wesseling

Pieter Wesseling

University of Amsterdam

Publications: 58

Matthias Preusser

Matthias Preusser

Medical University of Vienna

Publications: 57

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 57

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 57

Guido Reifenberger

Guido Reifenberger

Heinrich Heine University Düsseldorf

Publications: 54

Martin Bendszus

Martin Bendszus

University Hospital Heidelberg

Publications: 53

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 52

Marcel Kool

Marcel Kool

German Cancer Research Center

Publications: 50

Torsten Pietsch

Torsten Pietsch

University of Bonn

Publications: 48

Something went wrong. Please try again later.